You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 5, May 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperparathyroidism, Hypothyroidism, and Impaired Renal Function After 10 to 20 Years of Lithium Treatment

Harvey C. Stancer, MD; Nicholas Forbath, MD

Arch Intern Med. 1989;149(5):1042-1045.


Abstract

• Of 19 patients who had been receiving a therapeutic dosage of lithium carbonate for 10 to 20 years, 8(42%) were found to have some laboratory evidence of hyperparathyroidism. Of the 3 who had parathyroid surgery, 2 had hyperplasia and 1 had a solitary adenoma, an unusually high incidence of hyperparathyroidism. Unusual features of lithium-induced hyperparathyroidism in this series include (1) low urinary calcium excretion and the absence of nephrolithiasis, (2) normal urinary cyclic adenosine monophosphate excretion, and (3) normal plasma inorganic phosphate. Eight patients (42%) required treatment for hypothyroidism. Three patients (16%) had impaired kidney function. While these observations do not contraindicate the continued use of lithium carbonate in manic depression, they strongly emphasize the need for close laboratory surveillance.

(Arch Intern Med. 1989;149:1042-1045)



Author Affiliations

From the Clarke Institute of Psychiatry (Dr Stancer), the Toronto General Hospital (Dr Forbath), and the Departments of Psychiatry (Dr Stancer) and Medicine (Dr Forbath), University of Toronto, Canada.


Footnotes

Accepted for publication January 6,1989.

Reprint requests to Clarke Institute of Psychiatry, 250 College St, Toronto, Ontario, Canada M5T 1R8 (Dr Stancer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A case of lithium-associated hyperthyroidism
YAMAGISHI and YOKOYAMA-OHTA
Postgrad. Med. J. 1999;75:188b-188.
FULL TEXT  

Effects of Lithium Therapy on Bone Mineral Metabolism: A Two-Year Prospective Longitudinal Study
Mak et al.
J. Clin. Endocrinol. Metab. 1998;83:3857-3859.
ABSTRACT | FULL TEXT  

Alterations in Parathyroid Dynamics in Lithium-Treated Subjects
Haden et al.
J. Clin. Endocrinol. Metab. 1997;82:2844-2848.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.